Chapter 5 Lyssaviruses-Current Trends

Advances in Virus Research

Volumn 71, Issue , 2008, Pages 207-250

  Nadin Davis, Susan A ^a   Fehlner Gardiner, Christine ^a  

^a Ottawa Laboratory Fallowfield   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GLYCOPROTEIN; PHOSPHOPROTEIN; RABIES VACCINE; VIRUS PROTEIN;

ANIMAL; APOPTOSIS; CENTRAL NERVOUS SYSTEM; GENETIC ENGINEERING; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PATHOGENICITY; PATHOPHYSIOLOGY; RABIES; RABIES VIRUS; REVIEW; VIROLOGY;

ANIMALS; APOPTOSIS; CENTRAL NERVOUS SYSTEM; GENETIC ENGINEERING; GLYCOPROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; PHOSPHOPROTEINS; RABIES; RABIES VACCINES; RABIES VIRUS; VACCINES, DNA; VIRAL PROTEINS;

EID: 45749100791     PISSN: 00653527     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3527(08)00005-5     Document Type: Review

References (240)

1. Adams J.M., and Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science 281 (1998) 1322-1326
2. Akaike T., Weihe E., Schaefer M., Fu Z.F., Zheng Y.M., Vogel W., Schmidt H., Koprowski H., and Dietzschold B. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J. Neurovirol. 1 (1995) 118-125
3. Akkal D., Dum R.P., and Strick P.L. Supplementary motor area and presupplementary motor area: Targets of basal ganglia and cerebellar output. J. Neurosci. 27 (2007) 10659-10673
4. Aktan F. INOS-mediated nitric oxide production and its regulation. Life Sci. 75 (2004) 639-653
5. Albertini A.A.V., Schoehn G., Weissenhorn W., and Ruigrok R.W.H. Structural aspects of rabies virus replication. Cell Mol. Life Sci. 65 (2008) 282-294
6. Astic L., Saucier D., Coulon P., Lafay F., and Flamand A. The CVS strain of rabies virus as transneuronal tracer in the olfactory system of mice. Brain Res. 619 (1993) 146-156
7. Azzouz M., Le T., Ralph G.S., Walmsley L., Monani U.R., Lee D.C.P., Wilkes F., Mitrophanous K.A., Kingsman S.M., Burghes A.H.M., and Masarakis N.D. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J. Clin. Invest. 114 (2004) 1726-1731
8. Badrane H., and Tordo N. Host switching in Lyssavirus history from the chiroptera to the carnivora orders. J. Virol. 75 (2001) 8096-8104
9. Baer G.M. The history of rabies. In: Jackson A.C., and Wunner W.H. (Eds). Rabies. 2nd Ed. (2007), Academic Press, San Diego 1-22
10. Bahloul C., Ahmed S.B.H., B'chir B.I., Kharmachi H., Hayouni E.A., and Dellagi K. Post-exposure therapy in mice against experimental rabies: A single injection of DNA vaccine is as effective as five injections of cell culture-derived vaccine. Vaccine 22 (2003) 177-184
11. Bahloul C., Taieb D., Diouani M.F., Ahmed S.B.H., Chtourou Y., B'chir B.I., Kharmachi H., and Dellagi K. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions. Vaccine 24 (2006) 1063-1072
12. Bakker A.B.H., Marissen W.E., Kramer R.A., Rice A.B., Weldon W.C., Niezgoda M., Hanlon C.A., Thijsse S., Backus H.H.J., de Kruif J., Dietzschold B., Rupprecht C.E., et al. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J. Virol. 79 (2005) 9062-9068
13. Baloul L., Camelo S., and Lafon M. Up-regulation of Fas ligand (FasL) in the central nervous system: A mechanism of immune evasion by rabies virus. J. Neurovirol. 10 (2004) 372-382
14. Biek R., Henderson J.C., Waller L.A., Rupprecht C.E., and Real L.A. A high-resolution genetic signature of demographic and spatial expansion in epizootic rabies virus. Proc. Natl. Acad. Sci. USA 104 (2007) 7993-7998
15. Biswas S., Kalanidhi A.P., Ashok M.S., Reddy G.S., Srinivasan V.A., and Rangarajan P.N. Evaluation of rabies virus neutralizing antibody titres induced by intramuscular inoculation of rabies DNA vaccine in mice and Bonnet monkeys (Macaca radiata). Indian J. Exp. Biol. 39 (2001) 533-536
16. Blanton J.D., Meadows A., Murphy S.M., Manangan J., Hanlon C.A., Faber M.-L., Dietzschold B., and Rupprecht C.E. Vaccination of small Asian mongoose (Herpestes javanicus) against rabies. J. Wildl. Dis. 42 (2006) 663-666
17. Blanton J.D., Self J., Niezgoda M., Faber M.-L., Dietzschold B., and Rupprecht C. Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines. Vaccine 25 (2007) 7296-7300
18. Blondel D., Regad T., Poisson N., Pavie B., Harper F., Pandolfi P.P., de Thé H., and Chelbi-Alix M.K. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21 (2002) 7957-7970
19. Brochier B., Kieny M.P., Costy F., Coppens P., Bauduin B., Lecocq J.P., Languet B., Chappuis G., Desmettre P., Afiademanyo K., Libois R., and Pastoret P.-P. Large scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 354 (1991) 520-522
20. Brzózka K., Finke S., and Conzelmann K.-K. Identification of the rabies virus alpha/beta interferon antagonist: Phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 79 (2005) 7673-7681
21. Brzózka K., Finke S., and Conzelmann K.-K. Inhibition of interferon signaling by rabies virus phosphoprotein P: Activation-dependent binding of STAT1 and STAT2. J. Virol. 80 (2006) 2675-2683
22. Buchholz U.J., Finke S., and Conzelmann K.-K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73 (1999) 251-259
23. Camelo S., Castellanos J., Lafage M., and Lafon M. Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR. J. Virol. 75 (2001) 3427-3434
24. Champion J.M., Kean R.B., Rupprecht C.E., Notkins A.L., Koprowski H., Dietzschold B., and Hooper D.C. The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. J. Immunol. Methods 235 (2000) 81-90
25. Chelbi-Alix M.K., Vidy A., Bougrini J.E., and Blondel D. Rabies viral mechanisms to escape the IFN system: The viral protein P interferes with the IRF-3, Stat1 and PML nuclear bodies. J. Interferon Cytokine Res. 26 (2006) 271-280
26. Chenik M., Chebli K., and Blondel D. Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism. J. Virol. 69 (1995) 707-712
27. Childs J.E., Curns A.T., Dey M.E., Real L.A., Feinstein L., Bjørnstad O.N., and Krebs J.W. Predicting the local dynamics of epizootic rabies among raccoons in the United States. Proc. Natl. Acad. Sci. USA 97 (2000) 13666-13671
28. Christenson J.C., Holm B.M., Lechlitner S., Howell J.F., Wenger M., Roy-Burman A., Hsieh C.J., LaBar L., Petru A., Davis S., Simons N., Apolinario P., et al. Human rabies-Indiana and California, 2006. Morb. Mortal. Wkly. Rep. 56 (2007) 361-365
29. Clower D.M., Dum R.P., and Strick P.L. Basal ganglia and cerbellar inputs to 'AIP'. Cereb. Cortex 15 (2005) 913-920
30. Coulon P., Derbin C., Kucera P., Lafay F., Prehaud C., and Flamand A. Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. J. Virol. 63 (1989) 3550-3554
31. Cullingham C.I., Kyle C.J., and White B.N. An investigation of raccoon subspecies designations and their association with differences in population response to the rabies virus. The XVI International Conference on Rabies in the Americas, Ottawa, Canada (2005) 69
32. Davis P.L., Holmes E.C., Larrous F., Van der Poel W.H.M., Tjørnehøj K., Alonso W.J., and Bourhy H. Phylogeography, population dynamics, and molecular evolution of European bat lyssaviruses. J. Virol. 79 (2005) 10487-10497
33. Davis P.L., Bourhy H., and Holmes E.C. The evolutionary history and dynamics of bat rabies virus. Infect. Genet. Evol. 6 (2006) 464-473
34. Davis P.L., Rambaut A., Bourhy H., and Holmes E.C. The evolutionary dynamics of canid and mongoose rabies virus in southern Africa. Arch. Virol. 152 (2007) 1251-1258
35. Dhingra V., Li X., Liu Y., and Fu Z.F. Proteomic profiling reveals that rabies virus infection results in differential expression of host proteins involved in ion homeostasis and synaptic physiology in the central nervous system. J. Neurovirol. 13 (2007) 107-117
36. Dietzschold M.-L., Faber M., Mattis J.A., Pak K.Y., Schnell M.J., and Dietzschold B. In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife. Vaccine 23 (2004) 518-524
37. Echevarría J.E., Avellón A., Juste J., Vera M., and Ibáñez C. Screening of active lyssavirus infection in wild bat populations by viral RNA detection on oropharyngeal swabs. J. Clin. Microbiol. 39 (2001) 3678-3683
38. Ertl H.C. Rabies DNA vaccines for protection and therapeutic treatment. Expert Opin. Biol. Ther. 3 (2003) 639-644
39. Etessami R., Conzelmann K.-K., Fadai-Ghotbi B., Natelson B., Tsiang H., and Ceccaldi P.-E. Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: An in vitro and in vivo study. J. Gen. Virol. 81 (2000) 2147-2153
40. Faber M., Pulmanausahakul R., Hodawadekar S.S., Spitsin S., McGettigan J.P., Schnell M.J., and Dietzschold B. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J. Virol. 76 (2002) 3374-3381
41. Faber M., Pulmanausahakul R., Nagao K., Prosniak M., Rice A.B., Koprowski H., Schnell M.J., and Dietzschold B. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. USA 101 (2004) 16328-16332
42. Faber M., Bette M., Preuss M.A.R., Pulmanausahakul R., Rehnelt J., Schnell M.J., Dietzschold B., and Weihe E. Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J. Virol. 79 (2005) 15405-15416
43. Faber M., Faber M.-L., Papaneri A., Bette M., Weihe E., Dietzschold B., and Schnell M.J. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J. Virol. 79 (2005) 14141-14148
44. Faber M., Lamirande E.W., Roberts A., Rice A.B., Koprowski H., Dietzschold B., and Schnell M.J. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. J. Gen. Virol. 86 (2005) 1435-1440
45. Faber M., Faber M.-L., Li J., Preuss M.A.R., Schnell M.J., and Dietzschold B. Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus. J. Virol. 81 (2007) 7041-7047
46. Finke S., and Conzelmann K.K. Ambisense gene expression from recombinant rabies virus: Random packaging of positive- and negative-strand ribonucleoprotein complexes into rabies virions. J. Virol. 71 (1997) 7281-7288
47. Finke S., and Conzelmann K.K. Virus promoters determine interference by defective RNAs: Selective amplification of mini-RNA vectors and rescue from cDNA by a 3′ copy-back ambisense rabies virus. J. Virol. 73 (1999) 3818-3825
48. Finke S., Cox J.H., and Conzelmann K.K. Differential transcription attenuation of rabies virus genes by intergenic regions: Generation of recombinant viruses overexpressing the polymerase gene. J. Virol. 74 (2000) 7261-7269
49. Finke S., Brzózka K., and Conzelmann K.K. Tracking fluorescence-labeled rabies virus: Enhanced green fluorescent protein-tagged phosphoprotein P supports virus gene expression and formation of infectious particles. J. Virol. 78 (2004) 12333-12343
50. Fischer L., Minke J., Dufay N., Baudu P., and Audonnet J.-C. Rabies DNA vaccine in the horse: Strategies to improve serological responses. Vaccine 21 (2003) 4593-4596
51. Foley H.D., McGettigan J.P., Siler C.A., Dietzschold B., and Schnell M.J. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc. Natl. Acad. Sci. USA 97 (2000) 14680-14685
52. Foley H.D., Otero M., Orenstein J.M., Pomerantz R.J., and Schnell M.J. Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells. J. Virol. 76 (2002) 19-31
53. Foord A.J., Heine H.G., Pritchard L.I., Lunt R.A., Newberry K.M., Rootes C.L., and Boyle D.B. Molecular diagnosis of lyssaviruses and sequence comparison of Australian bat lyssavirus samples. Aust. Vet. J. 84 (2006) 225-230
54. Franka R., Constantine D.G., Kuzmin I., Velasco-Villa A., Reeder S.A., Streicker D., Orciari L.A., Wong A.J., Blanton J.D., and Rupprecht C.E. A new phylogenetic lineage of rabies virus associated with western pipistrelle bats (Pipistrellus hesperus). J. Gen. Virol. 87 (2006) 2309-2321
55. Fu Z.F., and Jackson A.C. Neuronal dysfunction and death in rabies virus infection. J. Neurovirol. 11 (2005) 101-106
56. Gastka M., Horvath J., and Lentz T.L. Rabies virus binding to the nicotinic acetylcholine receptor α subunit demonstrated by virus overlay protein binding assay. J. Gen. Virol. 77 (1996) 2437-2440
57. Gaytán S.P., Pásaro R., Coulon P., Bevengut M., and Hilaire G. Identification of central nervous system neurons innervating the respiratory muscles of the mouse: A transneuronal tracing study. Brain Res. Bull. 57 (2002) 335-339
58. Goudsmit J., Marissen W.E., Weldon W.C., Niezgoda M., Hanlon C.A., Rice A.B., de Kruif J., Dietzschold B., Bakker A.B.H., and Rupprecht C.E. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J. Infect. Dis. 193 (2006) 796-801
59. Graf W., Gerrits N., Yatim-Dhiba N., and Ugolini G. Mapping the oculomotor system: The power of transneuronal labelling with rabies virus. Eur. J. Neurosci. 15 (2002) 1557-1562
60. Gupta A., Chandrasekhar S., Pal R., Talwar G.P., and Singh O.M. Identification of novel transmembrane gene sequence and its use for cell-surface targeting of beta subunit of human chorionic gonadotropin. DNA Cell Biol. 17 (1998) 573-581
61. Gupta A.K., Blondel D., Choudhary S., and Banerjee A.K. The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C. J. Virol. 74 (2000) 91-98
62. Haller O., Kochs G., and Weber F. The interferon response circuit: Induction and suppression by pathogenic viruses. Virology 344 (2006) 119-130
63. Hanlon C.A., Kuzmin I.V., Blanton J.D., Weldon W.C., Manangan J.S., and Rupprecht C.E. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 111 (2005) 44-54
64. Hemachudha T., Sunsaneewitayakul B., Desudchit T., Suankratay C., Sittipunt C., Wacharapluesadee S., Khawplod P., Wilde H., and Jackson A.C. Failure of therapeutic coma and ketamine for therapy of human rabies. J. Neurovirol. 12 (2006) 407-409
65. Holmes E.C., Woelk C.H., Kassis R., and Bourhy H. Genetic constraints and the adaptive evolution of rabies virus in nature. Virology 292 (2002) 247-257
66. Hoshi E., Tremblay L., Féger J., Carras P.L., and Strick P.L. The cerebellum communicates with the basal ganglia. Nat. Neurosci. 8 (2005) 1491-1493
67. Hosokawa-Muto J., Ito N., Yamada K., Shimizu K., Sugiyama M., and Minamoto N. Characterization of recombinant rabies virus carrying double glycoprotein genes. Microbiol. Immunol. 50 (2006) 187-196
68. Hu R., Zhang S., Fooks A.R., Yuan H., Liu Y., Li H., Tu C., Xia X., and Xiao Y. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes Infect. 8 (2006) 1090-1097
69. Hu R.L., Liu Y., Zhang S.F., Zhang F., and Fooks A.R. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 25 (2007) 5301-5307
70. Hughes G.J., Páez A., Bóshell J., and Rupprecht C.E. A phylogenetic reconstruction of the epidemiological history of canine rabies virus variants in Colombia. Infect. Genet. Evol. 4 (2004) 45-51
71. Hughes G.J., Smith J.S., Hanlon C.A., and Rupprecht C.E. Evaluation of a TaqMan PCR assay to detect rabies virus RNA: Influence of sequence variation and application to quantification of viral loads. J. Clin. Microbiol. 42 (2004) 299-306
72. Hughes G.J., Orciari L.A., and Rupprecht C.E. Evolutionary timescale of rabies virus adaptation to North American bats inferred from the substitution rate of the nucleoprotein gene. J. Gen. Virol. 86 (2005) 1467-1474
73. Inase M., Tokuno H., Nambu A., Akazawa T., and Takada M. Corticostriatal and corticosubthalamic input zones from the presupplementary motor area in the macaque monkey: Comparison with the input zones from the supplementary motor area. Brain Res. 833 (1999) 191-201
74. Inoue K., Shoji Y., Kurane I., Iijima T., Sakai T., and Morimoto K. An improved method for recovering rabies virus from cloned cDNA. J. Virol. Methods 107 (2003) 229-236
75. Ito N., Takayama M., Yamada K., Sugiyama M., and Minamoto N. Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: Glycoprotein gene is associated with virulence for adult mice. J. Virol. 75 (2001) 9121-9128
76. Ito N., Takayama-Ito M., Yamada K., Hosokawa J., Sugiyama M., and Minamoto N. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol. Immunol. 47 (2003) 613-617
77. Ito N., Sugiyama M., Yamada K., Shimizu K., Takayama-Ito M., Hosokawa J., and Minamoto N. Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain. Microbiol. Immunol. 49 (2005) 971-979
78. Jackson A.C. Apoptosis in experimental rabies in bax-deficient mice. Acta Neuropathol. 98 (1999) 288-294
79. Jackson A.C. Screening of organ and tissue donors for rabies. Lancet 364 (2004) 2094-2095
80. Jackson A.C. Pathogenesis. In: Jackson A.C., and Wunner W.H. (Eds). Rabies. 2nd Ed. (2007), Academic Press, San Diego 341-381
81. Jackson A.C., and Park H. Apoptotic cell death in experimental rabies in suckling mice. Acta Neuropathol. 95 (1998) 159-164
82. Jackson A.C., and Park H. Experimental rabies virus infection of p75 neurotrophin receptor-deficient mice. Acta Neuropathol. 98 (1999) 641-644
83. Jackson A.C., and Rossiter J.P. Apoptosis plays an important role in experimental rabies virus infection. J. Virol. 71 (1997) 5603-5607
84. Jackson A.C., Rossiter J.P., and Lafon M. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J. Neurovirol. 12 (2006) 229-234
85. Jacob Y., Badrane H., Ceccaldi P.-E., and Tordo N. Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein. J. Virol. 74 (2000) 10217-10222
86. Jallet C., Jacob Y., Bahloul C., Drings A., Desmezieres E., Tordo N., and Perrin P. Chimeric lyssavirus glycoproteins with increased immunological potential. J. Virol. 73 (1999) 225-233
87. Jenkins G.M., Rambaut A., Pybus O.G., and Holmes E.C. Rates of molecular evolution in RNA viruses: A quantitative phylogenetic analysis. J. Mol. Evol. 54 (2002) 156-165
88. Johnson N., McKimmie C.S., Mansfield K.L., Wakeley P.R., Brookes S.M., Fazakerley J.K., and Fooks A.R. Lyssavirus infection activates interferon gene expression in the brain. J. Gen. Virol. 87 (2006) 2663-2667
89. Kang B., Oh J., Lee C., Park B.-K., Park Y., Hong K., Lee K., Cho B., and Song D. Evaluation of a rapid immunodiagnostic test kit for rabies virus. J. Virol. Methods 145 (2007) 30-36
90. Kassis R., Larrous F., Estaquier J., and Bourhy H. Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation. J. Virol. 78 (2004) 6543-6555
91. Kelly R.M., and Strick P.L. Rabies as a transneuronal tracer of circuits in the central nervous system. J. Neurosci. Methods 103 (2000) 63-71
92. Kelly R.M., and Strick P.L. Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate. J. Neurosci. 23 (2003) 8432-8444
93. Kelly R.M., and Strick P.L. Macro-architecture of basal ganglia loops with the cerebral cortex: Use of rabies virus to reveal multisynaptic circuits. Prog. Brain Res. 143 (2004) 449-459
94. Kinkade A., and Ware C.F. The DARC conspiracy-virus invasion tactics. Trends Immunol. 27 (2006) 362-367
95. Klingen Y., Conzelmann K.K., and Finke S. Double-labeled rabies virus-live tracking of enveloped virus transport. J. Virol. 82 (2008) 237-245
96. Ko K., Tekoah Y., Rudd P.M., Harvey D.J., Dwek R.A., Spitsin S., Hanlon C.A., Rupprecht C.E., Dietzschold B., Golovkin M., and Koprowski H. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. USA 100 (2003) 8013-8018
97. Kobayashi Y., Sato G., Shoji Y., Sato T., Itou T., Cunha E.M.S., Samara S.I., Carvalho A.A.B., Nociti D.P., Ito F.H., and Sakai T. Molecular epidemiological analysis of bat rabies viruses in Brazil. J. Vet. Med. Sci. 67 (2005) 647-652
98. Köbbert C., Apps R., Bechmann I., Lanciego J.L., Mey J., and Thanos S. Current concepts in neuroanatomical tracing. Prog. Neurobiol. 62 (2000) 327-351
99. Komarova A.V., Real E., Borman A.M., Brocard M., England P., Tordo N., Hershey J.W.B., Kean K.M., and Jacob Y. Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis. Nucleic Acids Res. 35 (2007) 1522-1532
100. Koser M.L., McGettigan J.P., Tan G.S., Smith M.E., Koprowski H., Dietzschold B., and Schnell M.J. Rabies virus nucleoprotein as a carrier for foreign antigens. Proc. Natl. Acad. Sci. USA 101 (2004) 9405-9410
101. Kucera P., Dolivo M., Coulon P., and Flamand A. Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brain. J. Virol. 55 (1985) 158-162
102. Kumar P., Wu H., McBride J.L., Jung K.-E., Kim M.H., Davidson B.L., Lee S.K., Shankar P., and Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature 448 (2007) 39-43
103. Kuzmin I.V., Hughes G.J., Botvinkin A.D., Orciari L.A., and Rupprecht C.E. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res. 111 (2005) 28-43
104. Kuzmin I.V., Hughes G.J., and Rupprecht C.E. Phylogenetic relationships of seven previously unclassified viruses within the family Rhabdoviridae using partial nucleoprotein gene sequences. J. Gen. Virol. 87 (2006) 2323-2331
105. Kuzmin I.V., Niezgoda M., Carroll D.S., Keeler N., Hossain M.J., Breiman R.F., Ksiazek T.G., and Rupprecht C.E. Lyssavirus surveillance in bats, Bangladesh. Emerg. Infect. Dis. 12 (2006) 486-488
106. Kuzmin I.V., Hughes G.J., Botvinkin A.D., Gribencha S.G., and Rupprecht C.E. Arctic and arctic-like rabies viruses: Distribution, phylogeny and evolutionary history. Epidemiol. Infect. 136 (2008) 509-519
107. Lafay F., Coulon P., Astic L., Saucier D., Riche D., Holley A., and Flamand A. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology 183 (1991) 320-330
108. Langevin C., and Tuffereau C. Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein. J. Virol. 76 (2002) 10756-10765
109. Langevin C., Jaaro H., Bressanelli S., Fainzilber M., and Tuffereau C. Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J. Biol. Chem. 277 (2002) 37655-37662
110. Lembo T., Niezgoda M., Velasco-Villa A., Cleaveland S., Ernest E., and Rupprecht C.E. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg. Infect. Dis. 12 (2006) 310-313
111. Le Mercier P., Jacob Y., Tanner K., and Tordo N. A novel expression cassette of lyssavirus shows that the distantly related Mokola virus can rescue a defective rabies virus genome. J. Virol. 76 (2002) 2024-2027
112. Leslie M.J., Messenger S., Rohde R.E., Smith J., Cheshier R., Hanlon C., and Rupprecht C.E. Bat-associated rabies virus in skunks. Emerg. Infect. Dis. 12 (2006) 1274-1277
113. Li X.-Q., Sarmento L., and Fu Z.F. Degeneration of neuronal processes after infection with pathogenic, but not attenuated, rabies viruses. J. Virol. 79 (2005) 10063-10068
114. Li J., Faber M., Papaneri A., Faber M.-L., McGettigan J.P., Schnell M.J., and Dietzschold B. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology 356 (2006) 147-154
115. Li J., McGettigan J.P., Faber M., Schnell M.J., and Dietzschold B. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway. Vaccine 26 (2008) 419-426
116. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon C.A., Shaddock J.H., Sanderlin D.S., and Rupprecht C.E. DNA immunization protects nonhuman primates against rabies virus. Nat. Med. 4 (1998) 949-952
117. Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., and Hanlon C.A. One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: Comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination. Vaccine 20 (2002) 838-844
118. Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., and Hanlon C.A. Rabies DNA vaccination of non-human primates: Post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers. Vaccine 20 (2002) 2221-2228
119. Lodmell D.L., Parnell M.J., Weyhrich J.T., and Ewalt L.C. Canine rabies DNA vaccination: A single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody. Vaccine 21 (2003) 3998-4002
120. Lodmell D.L., Ewalt L.C., Parnell M.J., Rupprecht C.E., and Hanlon C.A. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus. Vaccine 24 (2006) 412-416
121. Loewy A.D. Viruses as transneuronal tracers for defining neural circuits. Neurosci. Biobehav. Rev. 22 (1998) 679-684
122. Lu X., Miyachi S., Ito Y., Nambu A., and Takada M. Topographic distribution of output neurons in cerebellar nuclei and cortex to somatotropic map of primary motor cortex. Eur. J. Neurosci. 25 (2007) 2374-2382
123. Marissen W.E., Kramer R.A., Rice A., Weldon W.C., Niezgoda M., Faber M., Slootstra J.W., Meloen R.H., Clijsters-van der Horst M., Visser T.J., Jongeneelen M., Thijsse S., et al. Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: Fine mapping and escape mutant analysis. J. Virol. 79 (2005) 4672-4678
124. Mazarakis N.D., Azzouz M., Rohll J.B., Ellard F.M., Wilkes F.J., Olsen A.L., Carter E.E., Barber R.D., Baban D.F., Kingsman S.M., Kingsman A.J., O'Malley K., et al. Rabies virus glycoprotein pseudotyping on lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10 (2001) 2109-2121
125. McCoy C.E., and O'Neill L.A.J. The role of toll-like receptors in macrophages. Front. Biosci. 13 (2008) 62-70
126. McGettigan J.P., Foley H.D., Belyakov I.M., Berzofsky J.A., Pomerantz R.J., and Schnell M.J. Rabies virus based vectors expressing human immunodeficiency virus Type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates. J. Virol. 75 (2001) 4430-4434
127. McGettigan J.P., Sarma S., Orenstein J.M., Pomerantz R.J., and Schnell M.J. Expression and immunogenicity of human immunodeficiency virus type 1 gag expressed by a replication-competent rhabdovirus-based vaccine vector. J. Virol. 75 (2001) 8724-8732
128. McGettigan J.P., Pomerantz R.J., Siler C.A., McKenna P.M., Foley H.D., Dietzschold B., and Schnell M.J. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus Type 1 Gag have greatly reduced pathogenicity but are highly immunogenic. J. Virol. 77 (2003) 237-244
129. McGettigan J.P., Naper K., Orenstein J., Koser M., McKenna P.M., and Schnell M.J. Functional human immunodeficiency virus type 1(HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env expressed from a single Rhabdovirus-based vaccine vector genome. J. Virol. 77 (2003) 10889-10899
130. McGettigan J.P., Koser M.L., McKenna P.M., Smith M.E., Marvin J.M., Eisenlohr L.C., Dietzschold B., and Schnell M.J. Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2. Virology 344 (2006) 363-377
131. McKenna P.M., Koser M.L., Carlson K.R., Montefiori D.C., Letvin N.L., Papaneri A.B., Pomerantz R.J., Dietzschold B., Silvera P., McGettigan J.P., and Schnell M.J. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus (89.6P) Env and simian immunodeficiency virus (mac239) Gag are safe in rhesus macaques and protect from an AIDS-like disease. J. Infect. Dis. 195 (2007) 980-988
132. McKimmie C.S., Johnson N., Fooks A.R., and Fazakerley J.K. Viruses selectively upregulate Toll-like receptors in the central nervous system. Biochem. Biophys. Res. Commun. 336 (2005) 925-933
133. Mebatsion T. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. J. Virol. 75 (2001) 11496-11502
134. Mebatsion T., Schnell M.J., Cox J.H., Finke S., and Conzelmann K.K. Highly stable expression of a foreign gene from rabies virus vectors. Proc. Natl. Acad. Sci. USA 93 (1996) 7310-7314
135. Mentis G.Z., Gravell M., Hamilton R., Shneider N.A., O'Donovan M.J., and Schubert M. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins. J. Neurosci. Methods 157 (2006) 208-217
136. Messenger S.L., Smith J.S., and Rupprecht C.E. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin. Infect. Dis. 35 (2002) 738-747
137. Mochizuki H., Schwartz J.P., Tanaka K., Brady R.O., and Reiser J. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72 (1998) 8873-8883
138. Morcuende S., Delgado-Garcia J.M., and Ugolini G. Neuronal premotor networks involved in eyelid responses: Retrograde transneuronal tracing with rabies virus from the orbicularis oculi muscle in the rat. J. Neurosci. 22 (2002) 8808-8818
139. Morimoto K., Hooper D.C., Spitsin S., Koprowski H., and Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 73 (1999) 510-518
140. Morimoto K., McGettigan J.P., Foley H.D., Hooper D.C., Dietzschold B., and Schnell M.J. Genetic engineering of live rabies vaccines. Vaccine 19 (2001) 3543-3551
141. Moseley G.W., Filmer R.P., DeJesus M.A., and Jans D.A. Nucleocytoplasmic distribution of rabies virus P-protein is regulated by phosphorylation adjacent to C-terminal nuclear import and export signals. Biochem. 46 (2007) 12053-12061
142. Moseley G.W., Roth D.M., Dejesus M.A., Leyton D.L., Filmer R.P., Pouton C.W., and Jans D.A. Dynein light chain association sequences can facilitate nuclear protein import. Mol. Biol. Cell 18 (2007) 3204-3213
143. Nadin-Davis S.A. Molecular epidemiology. In: Jackson A.C., and Wunner W.H. (Eds). Rabies. 2nd Ed. (2007), Academic Press, San Diego 69-122
144. Nadin-Davis S.A., and Bingham J. Europe as a source of rabies for the rest of the world. In: King A.A., Fooks A.R., Aubert M., and Wandeler A.I. (Eds). Historical Perspective of Rabies in Europe and the Mediterranean Basin (2004), OIE, Paris 259-280
145. Nadin-Davis S.A., Abdel-Malik M., Armstrong J., and Wandeler A.I. Lyssavirus P gene characterization provides insights into the phylogeny of the genus and identifies structural similarities and diversity within the encoded phosphoprotein. Virology 298 (2002) 286-305
146. Nadin-Davis S.A., Turner G., Paul J.P.V., Madhusudana S.N., and Wandeler A.I. Emergence of arctic-like rabies lineage in India. Emerg. Infect. Dis. 13 (2007) 111-116
147. Nagaraj T., Vasanth J.P., Desai A., Kamat A., Madhusudana S.N., and Ravi V. Ante-mortem diagnosis of human rabies using saliva samples: Comparison of real time and conventional RT-PCR techniques. J. Clin. Virol. 36 (2006) 17-23
148. Nagarajan T., Rupprecht C.E., Dessain S.K., Rangarajan P.N., Thiagarajan D., and Srinivasan V.A. Human monoclonal antibody and vaccine approaches to prevent human rabies. Curr. Top. Microbiol. Immunol. 317 (2008) 67-101
149. Nakamichi K., Inoue S., Takasaki T., Morimoto K., and Kurane I. Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. J. Virol. 78 (2004) 9376-9388
150. Nakamichi K., Saiki M., Sawada M., Takayama-Ito M., Yamamuro Y., Morimoto K., and Kurane I. Rabies virus-induced activation of mitogen-activated protein kinase and NF- κB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia. J. Virol. 79 (2005) 11801-11812
151. Nassi J.J., and Callaway E.M. Multiple circuits relaying primate parallel visual pathways to the middle temporal area. J. Neurosci. 26 (2006) 12789-12798
152. Nel L.H., Niezgoda M., Hanlon C.A., Morril P.A., Yager P.A., and Rupprecht C.E. A comparison of DNA vaccines for the rabies-related virus, Mokola. Vaccine 21 (2003) 2598-2606
153. Nel L.H., Sabeta C.T., von Teichman B., Jaftha J.B., Rupprecht C.E., and Bingham J. Mongoose rabies in southern Africa: A re-evaluation based on molecular epidemiology. Virus Res. 109 (2005) 165-173
154. Norgren Jr. R.B., and Lehman M.N. Herpes simplex virus as a transneuronal tracer. Neurosci. Biobehav. Rev. 22 (1998) 695-708
155. Nuovo G.J., DeFaria D.L., Chanona-Vilchi J.G., and Zhang Y. Molecular detection of rabies encephalitis and correlation with cytokine expression. Mod. Pathol. 18 (2005) 62-67
156. Osorio J.E., Tomlinson C.C., Frank R.S., Haanes E.J., Rushlow K., Haynes J.R., and Stinchcomb D.T. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine 17 (1999) 1109-1116
157. Parveen Z., Mukhtar M., Rafi M., Wenger D.A., Siddiqui K.M., Siler C.A., Dietzschold B., Pomerantz R.J., Schnell M.J., and Dornburg R. Cell-type-specific gene delivery into neuronal cells in vitro and in vivo. Virology 314 (2003) 74-83
158. Pasdeloup D., Poisson N., Raux H., Gaudin Y., Ruigrok R.W.H., and Blondel D. Nucleocytoplasmic shuttling of the rabies virus P protein requires a nuclear localization signal and a CRM1-dependent nuclear export signal. Virology 334 (2005) 284-293
159. Patial S., Chaturvedi V.K., Rai A., Saini M., Chandra R., Saini Y., and Gupta P.K. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2. Vaccine 25 (2007) 4020-4028
160. Perrin P., Jacob Y., Aguilar-Sétien A., Loza-Rubio E., Jallet C., Desmézières E., Aubert M., Cliquet F., and Tordo N. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 18 (2000) 479-486
161. Poisson N., Real E., Gaudin Y., Vaney M.-C., King S., Jacob Y., Tordo N., and Blondel D. Molecular basis for the interaction between rabies virus phosphoprotein P and the dynein light chain LC8: Dissociation of dynein-binding properties and transcriptional functionality of P. J. Gen. Virol. 82 (2001) 2691-2696
162. Préhaud C., Mégret F., Lafage M., and Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79 (2005) 12893-12904
163. Prosniak M., Hooper D.C., Dietzschold B., and Koprowski H. Effect of rabies virus infection on gene expression in mouse brain. Proc. Natl. Acad. Sci. USA 98 (2001) 2758-2763
164. Prosniak M., Faber M., Hanlon C.A., Rupprecht C.E., Hooper D.C., and Dietzschold B. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J. Infect. Dis. 188 (2003) 53-56
165. Prosniak M., Zborek A., Scott G.S., Roy A., Phares T.W., Koprowski H., and Hooper D.C. Differential expression of growth factors at the cellular level in virus-infected brain. Proc. Natl. Acad. Sci. USA 100 (2003) 6765-6770
166. Pulmanausahakul R., Faber M., Morimoto K., Spitsin S., Weihe E., Hooper D.C., Schnell M.J., and Dietzschold B. Overexpression of cytochrome c by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. J. Virol. 75 (2001) 10800-10807
167. Pulmanausahakul R., Li J., Schnell M.J., and Dietzschold B. The glycoprotein and matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread. J. Virol. 82 (2007) 2330-2338
168. Qi P., Han J.X., Lu Y.Q., Wang C., and Bu F.F. Virus-encoded microRNAs: Future therapeutic targets?. Cell. Mol. Immunol. 3 (2006) 411-419
169. Rasalingam P., Rossiter J.P., Mebatsion T., and Jackson A.C. Comparative pathogenesis of the SAD-L16 strain of rabies virus and a mutant modifying the dynein light chain binding site of the rabies virus phosphoprotein in young mice. Virus Res. 111 (2005) 55-60
170. Rathelot J.A., and Strick P.L. Muscle representation in the macaque motor cortex: An anatomical perspective. Proc. Natl. Acad. Sci. USA 103 (2006) 8257-8262
171. Raux H., Flamand A., and Blondel D. Interaction of the rabies virus P protein with the LC8 dynein light chain. J. Virol. 74 (2000) 10212-10216
172. Real E., Rain J.-C., Battaglia V., Jallet C., Perrin P., Tordo N., Chrisment P., D'Alayer J., Legrain P., and Jacob Y. Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides. J. Virol. 78 (2004) 7410-7417
173. Real L.A., Henderson J.C., Biek R., Snaman J., Jack T.L., Childs J.E., Stahl E., Waller L., Tinline R., and Nadin-Davis S. Unifying the spatial population dynamics and molecular evolution of epidemic rabies virus. Proc. Natl. Acad. Sci. USA 102 (2005) 12107-12111
174. Real L.A., Russell C., Waller L., Smith D., and Childs J. Spatial dynamics and molecular ecology of North American rabies. J. Hered. 96 (2005) 1-8
175. Roy A., and Hooper D.C. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J. Virol. 81 (2007) 7993-7998
176. Roy A., Phares T.W., Koprowski H., and Hooper D.C. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J. Virol. 81 (2007) 1110-1118
177. Rupprecht C.E., Hanlon C.A., Blanton J., Manangan J., Morrill P., Murphy S., Niezgoda M., Orciari L.A., Schumacher C.L., and Dietzschold B. Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Res. 111 (2005) 101-105
178. Rupprecht C.E., Willoughby R., and Slate D. Current and future trends in the prevention, treatment and control of rabies. Expert Rev. Anti Infect. Ther. 4 (2006) 1021-1038
179. Russell C.A., Smith D.L., Childs J.E., and Real L.A. Predictive spatial dynamics and strategic planning for raccoon rabies emergence in Ohio. PLoS Biol. 3 (2005) 382-388
180. Russell C.A., Real L.A., and Smith D.L. Spatial control of rabies on heterogeneous landscapes. PLoS ONE 1 (2006) e27 doi:10.1371/journal.pone.0000027
181. Saha S., and Rangarajan P.N. Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses. J. Gen. Virol. 84 (2003) 1729-1735
182. Saha S., Murthy S., and Rangarajan P.N. Identification and characterization of a virus-inducible non-coding RNA in mouse brain. J. Gen. Virol. 87 (2006) 1991-1995
183. Schmiedel S., Panning M., Lohse A., Kreymann K.G., Gerloff C., Burchard G., and Drosten C. Case report on fatal human rabies infection in Hamburg, Germany, March 2007. Euro Surveill. 12 (2007) E070531.5
184. Schnell M.J., Mebatsion T., and Conzelmann K.K. Infectious rabies viruses from cloned cDNA. EMBO J. 13 (1994) 4195-4203
185. Schnell M.J., Foley H.D., Siler C.A., McGettigan J.P., Dietzschold B., and Pomerantz R.J. Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proc. Natl. Acad. Sci. USA 97 (2000) 3544-3549
186. Schnell M.J., Tan G.S., and Dietzschold B. The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines. J. Neurovirol. 11 (2005) 76-81
187. Scott C.A., Rossiter J.P., Andrew R.D., and Jackson A.C. Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice. J. Virol. 82 (2008) 513-521
188. Shimizu K., Ito N., Sugiyama M., and Minamoto N. Sensitivity of rabies virus to type 1 interferon is determined by the phosphoprotein gene. Microbiol. Immunol. 50 (2006) 975-978
189. Shimizu K., Ito N., Mita T., Yamada K., Hosokawa-Muto J., Sugiyama M., and Minamoto N. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res. 123 (2007) 154-160
190. Shoji Y., Inoue S., Nakamichi K., Kurane I., Sakai T., and Morimoto K. Generation and characterization of P gene-deficient rabies virus. Virology 318 (2004) 295-305
191. Siler C.A., McGettigan J.P., Dietzschold B., Herrine S.K., Dubuisson J., Pomerantz R.J., and Schnell M.J. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines. Virology 292 (2002) 24-34
192. Sloan S.E., Hanlon C., Weldon W., Niezgoda M., Blanton J., Self J., Rowley K.J., Mandell R.B., Babcock G.J., Thomas Jr. W.D., Rupprecht C.E., and Ambrosino D.M. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine 25 (2007) 2800-2810
193. Smith D.L., Lucey B., Waller L.A., Childs J.E., and Real L.A. Predicting the spatial dynamics of rabies epidemics on heterogeneous landscapes. Proc. Natl. Acad. Sci. USA 99 (2002) 3668-3672
194. Smith D.L., Waller L.A., Russell C.A., Childs J.E., and Real L.A. Assessing the role of long-distance translocation and spatial heterogeneity in the raccoon rabies epidemic in Connecticut. Prev. Vet. Med. 71 (2005) 225-240
195. Smith M.E., Koser M., Xiao S., Siler C., McGettigan J.P., Calkins C., Pomerantz R.J., Dietzschold B., and Schnell M.J. Rabies virus glycoprotein as a carrier for anthrax protective antigen. Virology 353 (2006) 344-356
196. Srinivasan A., Burton E.C., Kuehnert M.J., Rupprecht C., Sutker W.L., Ksiazek T.G., Paddock C.D., Guarner J., Shieh W.-J., Goldsmith C., Hanlon C.A., Zoretic J., et al. Transmission of rabies virus from an organ donor to four transplant recipients. N. Engl. J. Med. 352 (2005) 1103-1111
197. Takayama-Ito M., Inoue K.-I., Shoji Y., Inoue S., Iijima T., Sakai T., Kurane I., and Morimoto K. A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein. Virus Res. 119 (2006) 208-215
198. Takayama-Ito M., Ito N., Yamada K., Sugiyama M., and Minamoto N. Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res. 115 (2006) 169-175
199. Tan G.S., McKenna P.M., Koser M.L., McLinden R., Kim J.H., McGettigan J.P., and Schnell M.J. Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach. Virology 331 (2005) 82-93
200. Tan G.S., Preuss M.A.R., Williams J.C., and Schnell M.A. The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral replication. Proc. Natl. Acad. Sci. USA 104 (2007) 7229-7234
201. Tang Y., Rampin O., Giuliano F., and Ugolini G. Spinal and brain circuits to motoneurons of the bulbospongiosus muscle: Retrograde transneuronal tracing with rabies virus. J. Comp. Neurol. 414 (1999) 167-192
202. Teng Q., Garrity-Moses M., Federici T., Tanase D., Liu J.K., Mazarakis N.D., Azzouz M., Walmsley L.E., Carlton E., and Boulis N.M. Trophic activity of rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro. Neurobiol. Dis. 20 (2005) 694-700
203. Tesoro Cruz E., Hernández González R., Alonso Morales R., and Aguilar-Setién A. Rabies DNA vaccination by the intranasal route in dogs. Dev. Biol. (Basel) 125 (2006) 221-231
204. Theerasurakarn S., and Ubol S. Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with onset and severity of illness. J. Neurovirol. 4 (1998) 407-414
205. Thoulouze M.-I., Lafage M., Schachner M., Hartmann U., Cremer H., and Lafon M. The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 72 (1998) 7181-7190
206. Thoulouze M.-I., Lafage M., Yuste V.J., Baloul L., Edelman L., Kroemer G., Israel N., Susin S.A., and Lafon M. High level of Bcl-2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces long-term infection. Virology 314 (2003) 549-561
207. Tinline R.R., and MacInnes C.D. Ecogeographic patterns of rabies in southern Ontario based on time series analysis. J. Wildl. Dis. 40 (2004) 212-221
208. Tordo N., Benmansour A., Calisher C., Dietzgen R.G., Fang R.-X., Jackson A.O., Kurath G., Nadin-Davis S., Tesh R.B., and Walker P.J. Rhabdoviridae. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. (Eds). Virus Taxonomy, VIIIth Report of the ICTV (2004), Academic Press, London 623-644
209. Trimarchi C.V., and Nadin-Davis S.A. Diagnostic evaluation. In: Jackson A.C., and Wunner W.H. (Eds). Rabies. 2nd Ed. (2007), Academic Press, San Diego 411-469
210. Tuffereau C., Leblois H., Bénéjean J., Coulon P., Lafay F., and Flamand A. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 172 (1989) 206-212
211. Tuffereau C., Bénéjean J., Blondel D., Kieffer B., and Flamand A. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 17 (1998) 7250-7259
212. NTR. J. Gen. Virol. 82 (2001) 2861-2867
213. Tuffereau C., Schmidt K., Langevin C., Lafay F., Dechant G., and Koltzenburg M. The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J. Virol. 81 (2007) 13622-13630
214. Ubol S., Sukwattanapan C., and Utaisincharoen P. Rabies virus replication induces Bax-related, caspase dependent apoptosis in mouse neuroblastoma cells. Virus Res. 56 (1998) 207-215
215. Ubol S., Sukwattanapan C., and Maneerat Y. Inducible nitric oxide synthase inhibition delays death of rabies virus-infected mice. J. Med. Microbiol. 50 (2001) 238-242
216. Ubol S., Kasisith J., Mitmoonpitak C., and Pitidhamabhorn D. Screening of upregulated genes in suckling mouse central nervous system during the disease stage of rabies virus infection. Microbiol. Immunol. 50 (2006) 951-959
217. Ugolini G. Specificity of rabies virus as a transneuronal tracer of motor networks: Transfer from hypoglossal motoneurons to connected second-order and higher order central nervous system cell groups. J. Comp. Neurol. 356 (1995) 457-480
218. Ulmer J.B., Wahren B., and Liu M.A. Gene-based vaccines: Recent technical and clinical advances. Trends Mol. Med. 12 (2006) 216-222
219. Vidy A., Chelbi-Alix M., and Blondel D. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 79 (2005) 14411-14420
220. Vidy A., Bougrini J.E., Chelbi-Alix M.K., and Blondel D. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J. Virol. 81 (2007) 4255-4263
221. Viemari J.C., Bévengut M., Burnet H., Coulon P., Pequignot J.M., Tiveron M.C., and Hilaire G. Phox2a gene, A6 neurons, and noradrenaline are essential for development of normal respiratory rhythm in mice. J. Neurosci. 24 (2004) 928-937
222. Vos A., Neubert A., Pommerening E., Müller T., Döhner L., Neubert L., and Hughes K. Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. J. Gen. Virol. 82 (2001) 2191-2197
223. Wacharapluesadee S., and Hemachudha T. Nucleic-acid sequence based amplification in the rapid diagnosis of rabies. Lancet 358 (2001) 892-893
224. Wakeley P.R., Johnson N., McElhinney L.M., Marston D., Sawyer J., and Fooks A.R. Development of a real-time, TaqMan reverse transcription-PCR assay for detection and differentiation of lyssavirus genotypes 1, 5, and 6. J. Clin. Microbiol. 43 (2005) 2786-2792
225. Wang Z.W., Sarmento L., Wang Y., Li X.-Q., Dhingra V., Tseggai T., Jiang B., and Fu Z.F. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 79 (2005) 12554-12565
226. Wickersham I.R., Finke S., Conzelmann K.K., and Callaway E.M. Retrograde neuronal tracing with a deletion-mutant rabies virus. Nat. Methods 4 (2007) 47-49
227. Wickersham I.R., Lyon D.C., Barnard R.J.O., Mori T., Finke S., Conzelmann K.K., Young J.A.T., and Callaway E.M. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron 53 (2007) 639-647
228. Willoughby R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., and Rupprecht C.E. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 352 (2005) 2508-2514
229. World Health Organization. WHO expert consultation on rabies, 2004. First Report: WHO technical report series #931 (2005), World Health Organization, Geneva, Switzerland
230. Wu X., and Rupprecht C.E. Glycoprotein gene relocation in rabies virus. Virus Res. 131 (2008) 95-99
231. Wu X., Franka R., Velasco-Villa A., and Rupprecht C.E. Are all lyssavirus genes equal for phylogenetic analyses?. Virus Res. 129 (2007) 91-103
232. Wunner W.H. Rabies virus. In: Jackson A.C., and Wunner W.H. (Eds). Rabies. 2nd Ed. (2007), Academic Press, San Diego 23-68
233. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., and Ertl H.C.J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199 (1994) 132-140
234. Xiang Z.Q., Yang Y., Wilson J.M., and Ertl H.C.J. A replication defective recombinant adenovirus serves as a highly efficient vaccine carrier for the rabies virus glycoprotein. Virology 219 (1996) 220-227
235. Xiang Z., Gao G., Reyes-Sandoval A., Cohen C.J., Li Y., Bergelson J.M., Wilson J.M., and Ertl H.C.J. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J. Virol. 76 (2002) 2667-2675
236. Yamada K., Ito N., Takayama-Ito M., Sugiyama M., and Minamoto N. Multigenic relation to the attenuation of rabies virus. Microbiol. Immunol. 50 (2006) 25-32
237. Yan X., Prosniak M., Curtis M.T., Weiss M.L., Faber M., Dietzschold B., and Fu Z.F. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice. J. Neurovirol. 7 (2001) 518-527
238. Yan X., Mohankumar P.S., Dietzschold B., Schnell M.J., and Fu Z.F. The rabies virus glycoprotein determines the distribution of different rabies virus strains in the brain. J. Neurovirol. 8 (2002) 345-352
239. Yarosh O.K., Wandeler A.I., Graham F.L., Campbell J.B., and Prevec L. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 14 (1996) 1257-1264
240. Zhang S., Liu Y., Fooks A.R., Zhang F., and Hu R. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. Vaccine 26 (2008) 345-350